Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Activities
Net loss	$ (11,950)	$ (10,500)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	12,741	12,678
Amortization of deferred financing costs	1,023	308
Credit loss expense, net	7,229	305
Write-downs	381	213
Deferred income tax (benefit) expense	(109)	158
Share-based and other non-cash compensation	6,189	5,421
Unrealized foreign currency exchange loss	58	113
Realized and unrealized investment gains	(34)	(5,248)
Changes in assets and liabilities:
Accounts receivable	(2,654)	(13,744)
Inventories	(534)	437
Film assets	(5,107)	(2,213)
Deferred revenue	(830)	5,276
Changes in other operating assets and liabilities	(10,186)	(4,155)
Net cash used in operating activities	(3,783)	(10,951)
Investing Activities
Purchase of property, plant and equipment	(728)	(466)
Investment in equipment for joint revenue sharing arrangements	(4,587)	(1,540)
interest in film classified as a financial instrument	(4,731)
Acquisition of other intangible assets	(551)	(1,507)
Proceeds from sale of equity securities		17,769
Net cash (used in) provided by investing activities	(10,597)	14,256
Financing Activities
Proceeds from issuance of convertible notes, net		223,675
Purchase of capped calls related to convertible notes		(19,067)
Repayments of revolving credit facility borrowings		(255,000)
Credit facility amendment fees paid	(1,783)	(32)
Taxes withheld and paid on employee stock awards vested	(3,136)	(3,045)
Common shares issued - stock options exercised		824
Net cash used in financing activities	(13,035)	(52,645)
Effects of exchange rate changes on cash and cash equivalents	4	(245)
Decrease in cash and cash equivalents during period	(27,411)	(49,585)
Cash and cash equivalents, beginning of period	189,711	317,379
Cash and cash equivalents, end of period	162,300	$ 267,794
IMAX Corporation
Financing Activities
Repurchase of common shares	(6,272)
IMAX China
Financing Activities
Repurchase of common shares	$ (1,844)